Nusinersen Shows Lasting Benefits in Later-Onset SMA
In a groundbreaking longitudinal study poised to reshape the therapeutic landscape for spinal muscular atrophy (SMA), researchers have unveiled compelling evidence supporting the sustained efficacy...